Charles Wagner

Biography

 Charles Wagner, chief financial officer at Ortho Clinical Diagnostics, has a consistent record of creating value by improving the operational and financial health of complex global organizations across multiple industries. Prior to joining Ortho in June 2015, Wagner was executive vice president and chief financial officer at Bruker Corporation, a publicly traded, analytical instrumentation company focused on life science and material science applications. He was executive vice president of finance and administration and chief financial officer of Progress Software Corporation, a publicly traded provider of enterprise software, from November 2010 to March 2012. Wagner previously served as vice president and chief financial officer of the publicly traded Millipore Corporation, a global provider of products and services to the life science and biotechnology markets, from 2007 until July 2010, when Millipore was acquired by Merck KGaA. Wagner joined Millipore in 2002 and from 2003 to 2007 served as vice president, strategy and corporate development. From 1997 to 2002, he worked as a consultant in the corporate strategy and private equity practices at Bain & Company. Wagner started his career at Coopers & Lybrand from 1990 to 1995, where he earned his CPA. Since April 2014, Wagner has served as a director and chairman of the audit committee of Good Start Genetics Inc. Wagner previously served as a director of Bruker Corporation and member of its audit committee from August 2010 to June 2012. Wagner holds a B.S. in accounting from Boston College and an M.B.A. from Harvard Business School.    

Research Interest

 Charles Wagner, chief financial officer at Ortho Clinical Diagnostics, has a consistent record of creating value by improving the operational and financial health of complex global organizations across multiple industries. Prior to joining Ortho in June 2015, Wagner was executive vice president and chief financial officer at Bruker Corporation, a publicly traded, analytical instrumentation company focused on life science and material science applications. He was executive vice president of finance and administration and chief financial officer of Progress Software Corporation, a publicly traded provider of enterprise software, from November 2010 to March 2012. Wagner previously served as vice president and chief financial officer of the publicly traded Millipore Corporation, a global provider of products and services to the life science and biotechnology markets, from 2007 until July 2010, when Millipore was acquired by Merck KGaA. Wagner joined Millipore in 2002 and from 2003 to 2007 served as vice president, strategy and corporate development. From 1997 to 2002, he worked as a consultant in the corporate strategy and private equity practices at Bain & Company. Wagner started his career at Coopers & Lybrand from 1990 to 1995, where he earned his CPA. Since April 2014, Wagner has served as a director and chairman of the audit committee of Good Start Genetics Inc. Wagner previously served as a director of Bruker Corporation and member of its audit committee from August 2010 to June 2012. Wagner holds a B.S. in accounting from Boston College and an M.B.A. from Harvard Business School.